## Abstract The incidence of nephrotoxicity has been studied in 175 patients who received either gentamicin or tobramycin. All patients received individualized dosing regimens of the drugs based on pharmacokinetic parameters measured after the initial dose. Subsequent doses were calculated from the
Age-dependent nephrotoxicity and the pharmacokinetics of gentamicin in rats
β Scribed by R. Marre; N. Tarara; T. Louton; K. Sack
- Publisher
- Springer
- Year
- 1980
- Tongue
- English
- Weight
- 410 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
β¦ Synopsis
The pharmacokinetics and nephrotoxicity of gentamicin were studied in female Wistar rats of different ages. I.m. administration of 5 mg of gentamicin/kg revealed that young rats (90g) had lower peak serum levels and a prolonged elimination half-life, when compared with adult animals. After repeated injections, renal gentamicin concentrations were continuously lower in young rats during the entire experiment until the 20th day after the last dose. Nephrotoxicity, as measured by urinary excretion rates of tubular cells and malic dehydrogenase, was most pronounced in the old rats (260g) and distinctly less in the 210g animals. The young rats reacted with a slight but not significant increase in cellular and enzyme excretion. Since one cause of nephrotoxicity can be assumed to be intrarenal accumulation of gentamicin, it may be concluded that a deficient ability to concentrate aminoglycosides in the kidneys resulted in decreased nephrotoxic potential of gentamicin in the young rats.
π SIMILAR VOLUMES
## Abstract The effect of __Ξ±__βmelanocyte stimulating hormone (__Ξ±__βMSH) was investigated on gentamicinβinduced acute renal injury in rats. SpragueβDawley rats (200β250 g; __n__ = 8β10) were treated with gentamicin sulphate (GEN; 80 mg kg^β1^) or saline intraperitoneally for 7 consecutive days. _
## Abstract Gentamicin (GM) is used against serious and lifeβthreatening infections, but its use is limited by the occurrence of nephrotoxicity, which involves the generation of free radicals. In this work we tested the effect of a compound with antioxidant properties, tertamethylpyrazine (TMP), a
The pharmacokinetics of N-acetylprocainamide, administered orally or intravenously, were studied in 3-, 6-, and 12-month-old rats using a two-way crossover study design. At 3, 6, and 12 months of age, the half-life values of N-acetylprocainamide were 1.66, 1.82, and 2.29 hr, respectively; the appare